ICH Project ICH S1B (R1): Addendum to the Guideline on Testing for Carcinogenicity of Pharmaceuticals

July 28, 2021

ICH S1B(R1) "Addendum to the Guideline on Carcinogenicity Studies for Pharmaceuticals" has reached Step 2, and a Guideline Workshops was held jointly by Japan Pharmaceutical Manufacturers Association, Ministry of Health, Labor and Welfare, and Pharmaceuticals and Medical Devices Agency (PMDA).